德意志银行-xx医疗7月月度数据跟踪-20170809-deutschebank-chinahealthcaremonthlydatatracker,july2017.pdfVIP

China Healthcare Deutsche Bank Markets Research Asia Industry Date China China Healthcare 9 August 2017 Hong Kong Malaysia Industry Update Health Care Pharmaceuticals / Biotechnology Monthly data tracker: July 2017 Jack Hu, PhD Monthly data tracker: July 2017 Recent data suggest that: 1) drug consumption grew 12.1% YoY in 1H17 vs. 12% Research Analyst in 2016; 2) inpatient and outpatient traffic increased 4.0% and 1.0%, respectively, +852- 03 6208 in YTD April 2017; 3) growth in government spending on healthcare reached 20% YoY in 1H17, vs. 10% in 2016; 4) vitamin C prices remained high; 5) the price of Top picks 6-APA increased moderately, while that of 7-ACA dropped in July; 6) TCM raw Hengrui Medicine (600276.SS),CNY50.75 Buy material prices were mixed; and 7) corn price decreased to RMB1,680/ton in July. Sino Buy Biopharmaceutical (1177.HK),HKD6.98 Government spending, drug consumption, patient traffic and insurance Universal Medical (2666.HK),HKD6.37 Buy Growth in government spending in healthcare increased to % YoY in June 2017 Source: Deutsche Bank (to RMB217bn); YTD 1H17 growth reached 20% compared with 10% YoY in 2016. Meanwhile, growth in drug consumption fluctuated and reached 13.6% YoY in June 2017; YTD 1H17 growth was 12.1% vs. 12.